Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150001/S111

Medtronic MiniMed 630G System with Guardian Sensor (3); Guardian Sensor (3) Transfer to MPROC

Medtronic Minimed · Decision date Jul 21, 2026

FDA DECISIONP150001/S111

What did the FDA decide?

FDA records P150001/S111 as a supplement to PMA P150001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 21, 2026.

FDA approval order statement

undefined
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Clinical Chemistry
Decision date
Jul 21, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150001/S111
Regulatory pathway
PMA supplement
Product code
OZO
Decision code
OK30
Decision date
Jul 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated insulin dosing , threshold suspend.

Product code
OZO
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P150001/S110 · Related supplement

    Medtronic MiniMed 630G System

  2. P150001/S111 received

    Application receipt date recorded by FDA.

  3. P150001/S111 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P150001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150001

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MinimedPMA supplementOct 16, 2025FDA

Explore the linked device profile

Other records with product code OZO

Product / regulatory recordCompanyPathwayDecision dateSource
Enlite SensorP120010/S144
Medtronic, Inc.PMA supplementJul 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Minimed

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records